BackInnovAge Holding Overview
InnovAge Holding Corp

InnovAge Holding Target Price

Analysts' average 12-month price target for InnovAge Holding is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.4

Average Target Price

$13.5043.6% upside

2 analysts in the last 4 months

High: $14 | Low: $13

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09KeyBanc$1448.9% upsideOpen
2026-08-21KeyBancMatthew Gillmor$1338.3% upsideOpen
2023-02-08J.P. Morgan$814.9% downsideOpen
2022-11-23Goldman Sachs$814.9% downsideOpen
2022-11-16Citigroup$814.9% downsideOpen
2022-09-15Barclays$546.8% downsideOpen
2022-04-20Piper Sandler$546.8% downsideOpen

InnovAge Holding (INNV) FAQ

As of the most recent data, INNV shows a target price of $14. Scroll down for historical charts and peer comparison views.

If InnovAge Holding moved to the average analyst target of $14, shares would be roughly 43.6% higher than $9.4. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of InnovAge Holding's earnings trajectory.

Besides this target price page, Stockcircle has InnovAge Holding's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $14) with ownership activity and broader fundamentals.

InnovAge Holding's target price is $14; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.